Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project

References

• Akaike H. (1974). A new look at the statistical model identification. IEEE Trans Aut Control. 19:716–23.
   Web of Science ®Google Scholar
• American Diabetes Association. (2012). Standards of medical care in diabetes – 2012. Diabetes Care. 35:S1–110.
   PubMed Web of Science ®Google Scholar
• Astrup AS, Nielsen FS, Rossing P, et al. (2007). Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: A follow-up study. J Hypertens. 25:2479–85.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC. (2010). Sex differences in the administration-time dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects. Chronobiol Int. 27:345–62.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC. (2013). Ambulatory blood pressure monitoring for the early identificaton of hypertension in pregnancy. Chronobiol Int. 30:233–59.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC, Chayán L, et al. (2009). Circadian pattern of ambulatory blood pressure in untreated hypertensive patients with and without metabolic syndrome. Chronobiol Int. 26:1189–205.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC, Mojón A, et al. (1997a). Circadian blood pressure variability in healthy and complicated pregnancies. Hypertension. 30:603–10.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC, Mojón A, et al. (1997b). Blood pressure variability during gestation in healthy and complicated pregnancies. Hypertension. 30:611–8.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC, Mojón A, Fernández JR. (2013a). Cardiovascular risk of resistant hypertension: Dependence on treatment-time regimen of blood pressure-lowering medications. Chronobiol Int. 30:340–52.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Moyá A, Crespo JJ, et al. (2013b). Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int. 30:99–115.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Ucieda R, Hermida RC. (2013c). Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int. 30:260–79.
   PubMed Web of Science ®Google Scholar
• Ben-Dov IZ, Kark JD, Ben-Ishay D, et al. (2007). Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension. 49:1235–41.
   Google Scholar
• Bilo G, Giglio A, Styczkiewicz K, et al. (2005). How to improve the assessment of 24-h blood pressure variability. Blood Press. Monit. 10:321–23.
   PubMed Web of Science ®Google Scholar
• Black HR, Elliott WJ, Grandits G, et al. (2003). Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA. 289:2073–82.
   PubMed Web of Science ®Google Scholar
• Boggia J, Li Y, Thijs L, et al. (2007). Prognostic accuracy of day versus night ambulatory blood pressure: A cohort study. Lancet. 370:1219–29.
   PubMed Web of Science ®Google Scholar
• Bouhanick B, Bongard V, Amar J, et al. (2008). Prognostic value of nocturnal blood pressure and reverse-dipping status on the occurrence of cardiovascular events in hypertensive diabetic patients. Diabetes Metab. 34:560–7.
   PubMed Web of Science ®Google Scholar
• Brotman DJ, Davidson MB, Boumitri M, Vidt DG. (2008). Impaired diurnal blood pressure variation and all-cause mortality. Am J Hypertens. 21:92–7.
   PubMed Web of Science ®Google Scholar
• Burnham KP, Anderson DR. (2004). Model selection and multimodel inference: A practical information-theoretic approach. New York: Springer-Verlag.
   Google Scholar
• Chiang CE, Wang TD, Ueng KC, et al. ( 2015). 2015 guidelines of the taiwan society of cardiology and the taiwan hypertension society for the management of hypertension. J Chin Med Assoc. 78:1–47
   PubMed Web of Science ®Google Scholar
• Clement DL, De Buyzere ML, De Bacquer DA, et al. (2003). Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 348:2407–15.
   PubMed Web of Science ®Google Scholar
• Cox DR. (1972). Regression models and life-tables. J R Stat Soc B. 34:187–220.
   Google Scholar
• Crespo C, Aboy M, Fernández JR, Mojón A. (2012). Automatic identification of activity-rest periods based on actigraphy. Med Biol Eng Comput. 50:329–40.
   PubMed Web of Science ®Google Scholar
• Crespo C, Fernández JR, Aboy M, Mojón A. (2013). Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular risk. Chronobiol Int. 30:43–54.
   PubMed Web of Science ®Google Scholar
• Crespo JJ, Piñeiro L, Otero A, et al. (2013). Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease. Chronobiol Int. 30:159–75.
   PubMed Web of Science ®Google Scholar
• Dolan E, Stanton A., Thijs L, et al. (2005). Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension. 46:156–61.
   PubMed Web of Science ®Google Scholar
• Dolan E, Thijs L, Li Y, et al. (2006). Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the dublin outcome study. Hypertension. 47:365–70.
   PubMed Web of Science ®Google Scholar
• Easton J, Saver J, Albers GW, et al. (2009). Definition and evaluation of transient ischemic attack: A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 40:2276–93.
   PubMed Web of Science ®Google Scholar
• Eguchi K, Pickering TG, Hoshide S, et al. (2008). Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens. 21:443–50.
   PubMed Web of Science ®Google Scholar
• Fabbian F, Smolensky MH, Tiseo R, et al. (2013). Dipper and non-dipper blood pressure 24-hour patterns: Circadian rhythm-dependent physiologic and pathophysiologic mechanisms. Chronobiol Int. 30:17–30.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Celis H, Thijs L, et al. (2008). Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 51:55–61.
   PubMed Web of Science ®Google Scholar
• Fan HQ, Li Y, Thijs L, et al. (2010). Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 28:2036–45.
   PubMed Web of Science ®Google Scholar
• Fernández JR, Hermida RC. (1998). Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol Int. 15:191–204.
   PubMed Web of Science ®Google Scholar
• Fernández JR, Mojón A, Hermida RC. (2004). Comparison of parameters from rhythmometric models with multiple components on hybrid data. Chronobiol Int. 21:467–82.
   Web of Science ®Google Scholar
• Fernández JR, Mojón A, Hermida RC, Alonso I. (2003). Methods for comparison of parameters from longitudinal rhythmometric models with multiple components. Chronobiol Int. 20:495–513.
   PubMed Web of Science ®Google Scholar
• Frank M, Peyrard S, Bobrie G, Azizi, M. (2010). Method of mean value calculation as an additional source of variability in ambulatory blood pressure measurement. Am J Hypertens. 23:725–31.
   PubMed Web of Science ®Google Scholar
• Gradman AH. (2011). Sleep-time blood pressure. A validated therapeutic target. J Am Coll Cardiol. 58:1174–5.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, et al. (2005). Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood institute scientific statement. Circulation. 112:2735–52.
   PubMed Web of Science ®Google Scholar
• Hermida RC. (1999). Time-qualified reference values for 24h ambulatory blood pressure monitoring. Blood Press Monit. 4:137–47.
   PubMedGoogle Scholar
• Hermida RC. (2007). Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: Rationale and design of the MAPEC study. Chronobiol Int. 24:749–75.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. (2002). Prognostic value of office and ambulatory blood pressure measurements in pregnancy. Hypertension. 40:298–303.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. (2003). Sampling requirements for ambulatory blood pressure monitoring in the diagnosis of hypertension in pregnancy. Hypertension. 42:619–24.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. (2009). Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: Improved blood pressure control with bedtime dosing. Hypertension. 54:40–6.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. (2016). Ambulatory blood pressure monitoring in special populations: During pregnancy. In White WB, ed. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics, 3rd edition. New York: Springer, pp. 253–76.
   Google Scholar
• Hermida RC, Ayala DE, Calvo C. (2005a). Administration time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr Opin Nephrol Hypertens. 14:453–9.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, et al. (2003c). Administration-time dependent effects of aspirin on blood pressure in untreated hypertensive patients. Hypertension. 41:1259–67.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, et al. (2005c). Effects of the time of day of antihypertensive treatment on the ambulatory blood pressure pattern of patients with resistant hypertension. Hypertension. 46:1053–9.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, et al. (2005d). Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives. Hypertension. 46:1060–8.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, et al. (2007a). Chronotherapy of hypertension: Administration-time dependent effects of treatment on the circadian pattern of blood pressure. Adv Drug Deliv Rev. 59:923–39.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, López JE. (2005b). Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients. J Am Coll Cardiol. 46:975–83.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Chayán L, et al. (2009a). Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int. 26:61–79.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Crespo JJ, et al. (2013a). Influence of age and hypertension treatment-time on ambulatory blood presure in hypertensive patients. Chronobiol Int. 30:176–91.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Calvo C. (2007b). Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension. 50:715–22.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Calvo C. (2008a). Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension. 51:69–76.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, et al. (1999). Administration time-dependent effects of aspirin in women at differing risk for preeclampsia. Hypertension. 34:1016–23.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, et al. (2002a). Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol Int. 19:461–81.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, et al. (2004a). Reproducibility of the tolerance-hyperbaric test for diagnosing hypertension in pregnancy. J Hypertens. 22:565–72.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. Fernandez JR, et al. (2007c). Influence of measurement duration and frequency on ambulatory blood pressure monitoring. Rev Esp Cardiol. 60:131–8.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, et al. (2011a). Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am J Hypertens. 24:383–91.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, et al. (2013c). Administration-time-differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol Int. 30:280–314.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A. (2013b). Sleep-time blood pressure: Prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int. 30:68–86.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, et al. (2010a). Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol Int. 27:560–74.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, et al. (2010b). Chronotherapy with valsartan/amlodipine combination in essential hypertension: Improved blood pressure control with bedtime dosing. Chronobiol Int. 27:1287–303.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, et al. (2013d). Ambulatory blood pressure monitoring: Importance of sampling rate and duration – 48 versus 24 hours – on the accurate assessment of cardiovascular risk. Chronobiol Int. 30:55–67.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Iglesias M. (2001a). Predictable blood pressure variability in healthy and complicated pregnancies. Hypertension. 38:736–41.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Iglesias M. (2003a). Administration-time dependent influence of aspirin on blood pressure in pregnant women. Hypertension. 41:651–6.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Iglesias M. (2003b). Circadian rhythm of blood pressure challengues office values as the “gold standard” in the diagnosis of gestational hypertension. Chronobiol Int. 20:135–56.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Iglesias M, et al. (1997a). Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension. 30:589–95.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. (1998). Blood pressure excess for the early identification of gestational hypertension and preeclampsia. Hypertension. 31:83–9.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. (2000a). Blood pressure patterns in normal pregnancy, gestational hypertension and preeclampsia. Hypertension. 36:149–58.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. (2003d). Differences in circadian blood pressure variability during gestation between healthy and complicated pregnancies. Am J Hypertens. 16:200–8.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. (2008b). Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension. Chronobiol Int. 25:950–70.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. (2011e). Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: Improved sleep-time blood pressure control with bedtime dosing. Chronobiol Int. 28:601–10.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. (2013i). Differences between men and women in ambulatory blood pressure thresholds for diagnosis of hypertension based on cardiovascular outcomes. Chronobiol Int. 30:221–32.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. (2014a). Sleep-time ambulatory blood pressure as a novel therapeutic target for cardiovascular risk reduction. J Human Hypertens. 28:567–74.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2001b). Time-qualified reference values for ambulatory blood pressure monitoring in pregnancy. Hypertension. 38:746–52.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2008c). Chronotherapy with nifedipine GITS in hypertensive patients: Improved efficacy and safety with bedtime dosing. Am J Hypertens. 21:948–54.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2009b). Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension. Am J Hypertens. 22:896–903.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2010c). Influence of circadian time of hypertension treatment on cardiovascular risk: Results of the MAPEC study. Chronobiol Int. 27:1629–51.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2010d). Effects of time of antihypertensive treatment on ambulatory blood pressure and clinical characteristics of subjects with resistant hypertension. Am J Hypertens. 23:432–9.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011b). Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 58:1165–73.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011c). Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care. 34:1270–6.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011d). Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol. 22:2313–21.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2012a). Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension. Am J Hypertens. 25:297–305.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2012b). Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Am J Hypertens. 25:325–34.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013e). Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level – The “normotensive non-dipper” paradox. Chronobiol Int. 30:87–98.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013f). Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes. Chronobiol Int. 30:132–44.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013g). Cardiovascular risk of essential hypertension: Influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol Int. 30:315–27.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013h). Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk. Chronobiol Int. 30:328–39.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2015a). Sleep-time blood pressure as a therapeutic target for reducing the risk of developing chronic kidney disease [Abstract]. J Hypertens. 33:e457.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2016a). Sleep-time BP: Prognostic marker of type 2 diabetes and therapeutic target for prevention. Diabetologia. 59:244–54.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2016b). Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: A randomised controlled trial. Diabetologia. 59:255–65.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Portaluppi F. (2007d). Circadian variation of blood pressure: The basis for the chronotherapy of hypertension. Adv Drug Deliv Rev. 59:904–22.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Ríos MT, et al. (2014b). Around-the-clock ambulatory blood pressure monitoring is required to properly diagnose resistant hypertension and assess associated vascular risk. Curr Hypertens Rep. 16:445.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, et al. (2013j). Chronotherapy improves blood pressure control and reduces vascular risk in CKD. Nat Rev Nephrol. 9:358–68.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, et al. (2014c). Chronotherapeutics of conventional blood pressure-lowering medications: Simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders. Curr Hypertens Rep. 16:412.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, et al. (2016c). Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res. In press. doi: 10.1038/hr.2015.142.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, et al. (2002b). Evaluation of the extent and duration of the “ABPM effect” in hypertensive patients. J Am Coll Cardiol. 40:710–7.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, et al. (2002c). Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J Hypertens. 20:1097–104.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, et al. (2003e). Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension. 42:283–90.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, et al. (2003f). Seasonal variation of fibrinogen in dipper and nondipper hypertensive patients. Circulation. 108:1101–6.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, et al. (2004b). Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol Int. 21:277–96.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, et al. (2005e). Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens. 23:1913–22.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, et al. (2005g). Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol Int. 22:755–76.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, et al. (2007e). Dose- and administration-time-dependent effects of nifedipine GITS on ambulatory blood pressure in hypertensive subjects. Chronobiol Int. 24:471–93.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, López JE. (2005f). Decrease in urinary albumin excretion associated to the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension. 46:960–8.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Chayán L, Ayala DE, et al. (2009c). Association of metabolic syndrome and blood pressure non-dipping profile in untreated hypertension. Am J Hypertens. 22:307–13.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Chayán L, Ayala DE, et al. (2011f). Relationship between metabolic syndrome, circadian time of treatment, and blood pressure non-dipping profile in essential hypertension. Chronobiol Int. 28:509–19.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Fernández JR. (1996). Computation of time-specified tolerance intervals for ambulatorily monitored blood pressure. Biomed Instrum Technol. 30:257–66.
   PubMedGoogle Scholar
• Hermida RC, Fernández JR, Ayala DE, et al. (1997b). Influence of aspirin usage on blood pressure. Dose and administration-time dependencies. Chronobiol Int. 14:619–37.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Fernández JR, Ayala DE, et al. (2001). Circadian rhythm of double (rate-pressure) product in healthy normotensive young subjects. Chronobiol Int. 18:475–89.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Fernández JR, Ayala DE, et al. (2004c). Circadian time-qualified tolerance intervals for ambulatory blood pressure monitoring in the diagnosis of hypertension. Chronobiol Int. 21:149–70.
   Web of Science ®Google Scholar
• Hermida RC, Fernández JR, Mojón A, Ayala DE. (2000b). Reproducibility of the hyperbaric index as a measure of blood pressure excess. Hypertension. 35:118–25.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Fernández JR, Ayala DE. (1996). Computer-based medical system for the computation of blood pressure excess in the diagnosis of hypertension. Biomed Instrum Technol. 30:267–83.
   PubMedGoogle Scholar
• Hermida RC, Mojón A, Fernández JR, et al. (2002d). The tolerance-hyperbaric test: A chronobiologic approach for improved diagnosis of hypertension. Chronobiol Int. 19:1183–211.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ríos MT, Crespo JJ, et al. (2013k). Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension. Chronobiol Int. 30:192–206.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH. (2004). Chronotherapy of hypertension. Curr Opin Nephrol Hypertens. 13:501–5.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, et al. (2013l). 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM). Chronobiol Int. 30:355–410.
   Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, et al. (2014d). Abnormalities in chronic kidney disease of ambulatory blood pressure 24 h patterning and normalization by bedtime hypertension chronotherapy. Nephrol Dial Transplant. 29:1160–7.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, Portaluppi F. (2015b). Ambulatory blood pressure monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults. Chronobiol Int. 32:1329–42.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Zamarrón C, Ayala DE, et al. (2004d). Effect of continuous positive airway pressure on ambulatory blood pressure in patients with obstructive sleep apnea. Blood Press Monit. 9:193–202.
   PubMed Web of Science ®Google Scholar
• Holm S. (1979). A simple sequentially rejective multiple test procedure. Scand J Stat. 6:65–70.
   Web of Science ®Google Scholar
• Hoshino A, Nakamura T, Matsubara H. (2010). The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy. Clin Exp Hypertens. 32:416–22.
   PubMed Web of Science ®Google Scholar
• Ingelsson E, Bjorklund-Bodegard K, Lind L, et al. (2006). Diurnal blood pressure pattern and risk of congestive heart failure. JAMA. 295:2859–66.
   PubMed Web of Science ®Google Scholar
• Kaplan ER, Meier P. (1958). Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457–481.
   Web of Science ®Google Scholar
• Kario K, Pickering TG, Matsuo T, et al. (2001). Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 38:852–7.
   PubMed Web of Science ®Google Scholar
• Kario K, Pickering TG, Umeda Y, et al. (2003). Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation. 107:1401–6.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. ( 2013). Kidney Int Suppl. 3:1–150.
   Web of Science ®Google Scholar
• Kikuya M, Ohkubo T, Asayama K, et al. (2005). Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality. The Ohasama Study. Hypertension. 45:240–5.
   PubMed Web of Science ®Google Scholar
• Kleinbaum DG. (1996). Survival analysis. New York: Springer-Verlag, 324 pp.
   Google Scholar
• Koga H, Hayashi J, Yamamoto M, Kitamoto K. (2005). Prevention of morning surge of hypertension by the evening administration of carvedilol. Jap Med Ass J. 48:398–403.
   Google Scholar
• Law MR, Morris JK, Wald NJ. (2009). Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 338:b1665
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. (2009). A new equation to estimate glomerular filtration rate. Ann Intern Med. 150:604–12.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang JG, Dolan E, et al. (2006). Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension. 47:359–64.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang JG, Gong L, et al. (1998). Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens. 16:1823–9.
   PubMed Web of Science ®Google Scholar
• Luepker RV, Apple FS, Christenson RH, et al. (2003). Case Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies: A Statement From the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation. 108:2543–9.
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. ( 2013). 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 31:1281–357.
   PubMed Web of Science ®Google Scholar
• Mantel N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chrmother Rep. 50:163–70.
   PubMedGoogle Scholar
• Meng Y, Zhang Z, Liang X, et al. (2010). Effects of combination therapy with amlodipine and fosinopril administered at different times on blood pressure and circadian blood pressure pattern in patients with essential hypertension. Acta Cardiol. 65:309–14.
   PubMed Web of Science ®Google Scholar
• Minutolo R, Agarwal R, Borrelli S, et al. (2011). Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 171:1090–8.
   PubMed Web of Science ®Google Scholar
• Mojón A, Ayala DE, Piñeiro L, et al. (2013). Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 30:145–58.
   PubMed Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 24:67–74.
   PubMed Web of Science ®Google Scholar
• Moyá A, Crespo JJ, Ayala DE, et al. (2013). Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes. Chronobiol Int. 30:116–31.
   PubMed Web of Science ®Google Scholar
• Nakano S, Fukuda M, Hotta F, et al. (1998). Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal events in NIDDM subjects. Diabetes. 47:1501–6.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. (2011). Hypertension: The clinical management of primary hypertension in adults. NICE Clinical Guidelines 127: Methods, evidence and recommendations. National Clinical Guidelines Centre, London, UK. http://guidance.nice.org.uk/CG/Wave2/14 [ last accessed 23 February 2016].
   Google Scholar
• Nelson RR, Gobel FL, Jorgensen CR, et al. (1974). Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation. 50:1179–89.
   PubMed Web of Science ®Google Scholar
• Octavio JA, Contreras J, Amair P, et al. (2010). Time-weighted vs. conventional quantification of 24-h average systolic and diastolic ambulatory blood pressures. J Hypertens. 28:459–64.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, et al. (2002). Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama study. J Hypertens. 20:2183–9.
   PubMed Web of Science ®Google Scholar
• Ohmori M, Fujimura A. (2005). ACE inhibitors and chronotherapy. Clin Exp Hypertens. 2 & 3:179–85.
   Web of Science ®Google Scholar
• Parati G. (2005). Blood pressure variability: Its measurement and significance in hypertension. J Hypertens. 23:S19–25.
   PubMed Web of Science ®Google Scholar
• Perloff D, Sokolow M, Cowan R. (1983). The prognostic value of ambulatory blood pressures. JAMA. 249:2792–8.
   PubMed Web of Science ®Google Scholar
• Piper MA, Evans CV, Burda BU, et al. (2015). Diagnosis and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 162:192–204.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Hermida RC. (2007). Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. Adv Drug Deliv Rev. 59:940–51.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911–29.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Tiseo R, Smolensky MH, et al. (2012). Circadian rhythms and cardiovascular health. Sleep Med Rev. 16:151–66.
   PubMed Web of Science ®Google Scholar
• Ríos MT, Domínguez-Sardiña M, Ayala DE, et al. (2013). Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood presure monitoring. Chronobiol Int. 30:207–20.
   PubMed Web of Science ®Google Scholar
• Roush GC, Fapohunda J, Kostis JB. (2014). Evening dosing of antihypertensive therapy to reduce cardiovascular events: A third type of evidence based on a systematic review and meta-analysis of randomized trials. J Clin Hypertens (Greenwich). 16:561–8.
   PubMed Web of Science ®Google Scholar
• Rydén L, Grant PJ, Anker SD, et al. (2013). ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 34:3035–87.
   PubMed Web of Science ®Google Scholar
• Salles GF, Cardoso CR, Muxfeldt ES. (2008). Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med. 168:2340–6.
   PubMed Web of Science ®Google Scholar
• Salles GF, Reboldi G, Fagard RH, et al. (2016). Prognostic impact of the nocturnal blood pressure fall in hypertensive patients: The ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 67:693–700.
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Ando K, Fujita T, et al. (2014). The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 37:253–390.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Ayala DE, Hermida RC. (2015a). Ambulatory blood pressure monitoring (ABPM) as THE reference standard to confirm diagnosis of hypertension in adults: Recommendation of the 2015 U.S. Preventive Services Task Force (USPSTF). Chronobiol Int. 2015;32:1320–22.
   Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, et al. (2010). Administration-time-dependent effect of blood pressure-lowering medications: Basis for the chronotherapy of hypertension. Blood Press Monit. 15:173–80.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Portaluppi F. (2015b). Bedtime hypertension chronotherapy: Concepts and patient outcomes. Curr Pharm Des. 21:773–90.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Portaluppi F. (2016a). Circadian mechanisms of 24-hour blood pressure regulation and patterning. Sleep Med Rev. 22: in press. doi: 10.1016/j.smrv.2016.02.003
   Google Scholar
• Smolensky MH, Hermida RC, Portaluppi F, et al. (2005). Chronotherapeutics in the treatment of hypertension. In: Oparil S, Weber MA, eds. Hypertension: A companion to Brenner and Rector’s the kidney. 2nd edition. Philadelphia, Pennsylvania: Elsevier Saunders, pp. 530–42.
   Google Scholar
• Smolensky MH, Portaluppi F, Hermida RC. (2016b). Circadian and cyclic environmental determinants of blood pressure patterning and implications for therapeutic interventions. In: White WB, ed. Blood pressure monitoring in cardiovascular medicine and therapeutics, Third Edition. New York: Springer, pp. 105–27.
   Google Scholar
• Smolensky MH, Siegel RA, Haus E, et al. (2012). Biological rhythms, drug delivery, and chronotherapeutics. In: Siepmann J, Siegel RA, Rathbone MJ (eds). Fundamentals and Applications of controlled release drug delivery. Heildelberg: Springer-Verlag, pp. 359–443.
   Google Scholar
• Staessen J, Fagard R, Lijnen P, et al. (1991). Ambulatory blood pressure monitoring in clinical trials. J Hypertens. 9:s13–9.
   Web of Science ®Google Scholar
• Staessen JA, Fagard R, Thijs L, et al. (1997). Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 350:757–64.
   PubMed Web of Science ®Google Scholar
• Sturrock ND, George E, Pound N, et al. (2000). Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet Med. 17:360–4.
   PubMed Web of Science ®Google Scholar
• Swedberg K, Cleland J, Dargie H, et al. (2005). Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005). The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 26:1115–40.
   PubMed Web of Science ®Google Scholar
• The ABC-H Investigators, Roush GC, Fagard RH, et al. (2014). Prognostic impact from clinic, daytime, and nighttime systolic blood pressure in 9 cohorts on 13,844 patients with hypertension. J Hypertens. 32:2332–40.
   PubMed Web of Science ®Google Scholar
• The ABC-H Investigators, Roush GC, Fagard RH, et al. (2015). Prognostic impact of sex-ambulatory blood pressure interactions in 10 cohorts on 17,312 patients diagnosed with hypertension. Systematic review and meta-analysis. J Hypertens. 33:212–20.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Porcellati C, Schillaci G, et al. (1994). Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension. Hypertension. 24:793–801.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Borgioni C, et al. (1998). Ambulatory pulse pressure: A potent predictor of total cardiovascular risk in hypertension. Hypertension. 32:983–8.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Reboldi G, et al. (2001). Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation. 103:2579–84.
   PubMed Web of Science ®Google Scholar
• White WB, Black HR, Weber MA, et al. (1998). Comparison of effects of controlled-onset extended-release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. Am J Cardiol. 81:424–31.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Sleight P, Pogue J, et al. (2000). Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 342, 145–53.
   PubMed Web of Science ®Google Scholar
• Zanchetti A. (2009). Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced? J Hypertens. 27:1509–20.
   Google Scholar
• Zeng J, Jia M, Ran H, et al. (2011). Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: Improved blood pressure control with bedtime dosing–a multicenter, open-label randomized Ministerio study. Hypertens Res. 34:767–72.
   PubMed Web of Science ®Google Scholar